|
"Randomized, Embedded, Multifactorial Adaptive Platform trial for Community- Acquired Pneumonia (REMAP-CAP)"
|
Ongoing
|
Ceftriaxone - Piperacillin Tazobactam - Azithromycin - Interferon β1-a - Hydrocortisone sodium suc... - Hydroxychloroquine - OSELTAMIVIR - Lopinavir-Ritonavir
|
3
|
CT20/001/R
|
NGHA-R
|
|
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Solifenacin succinate film-coated tablets (10 mg solifenacin succinate) versus Vesicare® film-coated tablets (10 mg solifenacin succinate), in healthy subjects under fasting condition.
|
Ongoing
|
solifenacin succinate
|
1
|
42767
|
Saudi Ajal
|
|
Randomized, two-way, two-period, single injectable dose, open-label, crossover, bioequivalence study to compare Enoxa pre-filled syringes (80 mg enoxaparin sodium) versus Clexane® pre-filled syringes (80 mg enoxaparin sodium), in healthy subjects under fasting condition.
|
Ongoing
|
Enoxa / Enoxaparin
|
3
|
21-2017
|
Saudi Ajal
|
|
Randomized, four-way, four-period, single oral dose, open-label, crossover, bioequivalence study to compare Tacrolimus Immediate-release capsules (5 mg tacrolimus) versus Prograf® Immediate-release capsules (5 mg tacrolimus), in healthy subjects under fasting conditions.
|
Ongoing
|
Tacrolimus/ Prograf
|
1
|
19-2017
|
Saudi Ajal
|
|
Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma
|
Ongoing
|
Sorafenib (Nexavar)
|
3
|
RTOG 1112
|
KFSH & RC-R
|
|
"Randomized clinical trial of neoadjuvant chemotherapy with denosumab compared to chemotherapy alone in hormonal receptor-positive, HER2-negative premenopausal breast cancer patients"
|
Ongoing
|
DENOSUMAB
|
3
|
20-610
|
King Abdullah Medical City (Makkah)
|
|
"randomised, multicentre, double-blind, placebo-controlled study of ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension (CTEPH)"
|
Completed
|
Ambrisentan 5 mg
|
3
|
AMB115811
|
KFMC
|
|
RAINBOW study: a randomized, controlled study evaluating the efficacy and safety of Ranibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity
|
Ongoing
|
Ranibizumab
|
3
|
CRFB002H2301 V 01
|
KFSH & RC-R
|
|
"PROSPECTIVE, RANDOMIZED, OPEN LABEL CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF DEXMEDETOMIDINE USE BEYOND 24 HOURS COMPARED WITH MIDAZOLAM IN CHILDREN ADMITTED TO PEDIATRIC INTENSIVE CARE UNIT (PICU) AT KASCH-MNGHA. (PROMISE)"
|
Rejected
|
Dexmedetomidine (Hospira)
|
3
|
RC20/160/R
|
King Abdulaziz Medical City NG (Riyadh)
|
|
Prospective, Randomized, Open label Controlled trial to evaluate the safety and efficacy of Dexmedetomidine Compared with Midazolam in children admitted to Pediatric Intensive Care unit (PICU) at KAMC-NGHA
|
Rejected
|
Dexmedetomidine (Precedex)
|
3
|
RC11/084/R
|
NGHA-R
|
